11:00–11:30
Evren Alici, PhD
Principal Researcher
Cell and Gene Therapy Group
Huddinge, Karolinska Institutet
Learn with ACRO
European Cell Therapy Translational Workshop
Join ACROBiosystems and Wyss Zurich at Superlab Suisse for a full-day workshop on knowledge that moves cell therapy programmes from early research toward clinical translation.
Date
21 October | 10:30–17:00
Location
Superlab Suisse Zurich
Format
In-person | hosted by ACROBiosystems & Wyss Zurich
Registration includes full workshop access, lunch, and the closing apéro.
Registration is open
Register your seat now
Discover the scientific insights, translational strategies, and networking opportunities that will advance your next research and development projects.
00
Days
00
Hours
00
Minutes
00
Seconds
Speakers Line-up
Meet the researchers and industry leaders who will share practical lessons on cell therapy translation, GMP manufacturing, and regulatory readiness.
11:30–12:00
Jenny Ann Prange, PhD
Head of Project Management
Wyss Zurich Regenerative Medicine Technologies Platform
From Bench to Bedside: Navigating GxP and Regulatory Challenges in Clinical Translation
Jenny will discuss qualified materials, process validation, documentation, cleanroom operations, and why regulatory readiness needs to start early.
13:15–13:45
Aline Bauer, PhD
Manufacturing Team Lead
Somagenetix AG
From Academic Research to GMP Manufacturing: Lessons from a Stem-Cell Gene Therapy Programme
Aline will share lessons from a stem-cell gene therapy programme, including manufacturability, collaboration between research and CMC teams, and first-in-human preparation.
13:45–14:15
Beau le Roy, PhD
Technical Sales Supervisor
ACROBiosystems
From Ex Vivo to In Vivo: What Do We Need For the Next Generation of Cell and Gene Therapy?
Hui will explore what the next generation of cell and gene therapy requires in delivery, biodistribution, monitoring, safety evaluation, and translational assessment.
14:30–15:00
Natalie Francis, PhD
Head of Process Development
Ocular Cell Therapy, King's College London
Translation of a Retinal Cell Therapy
Natalie will share the challenges her team has faced in moving retinal cell therapy research toward a clinical-stage therapy, including scale-up, analytical development, and regulatory requirements.
15:00–15:30
Stefan Gärtner
Head of Sterility Testing | Rapid and Alternative Methods
Labor LS SE & Co. KG
Microbiological Control Strategy for Cell-based Preparations
Stefan will share practical testing strategies and regulatory expectations designed to protect patient safety while supporting the rapid timelines common in cell and gene therapy products.
Agenda
Agenda at a glance
The workshop is structured to move from translational context into manufacturing, development, and control topics, with time built in for conversation throughout the day.
10:30-11:00
Registration and opening
Check in, meet the on-site team, and join the welcome session led by the moderator before the technical program begins.
11:00-12:00
Morning translational sessions
Two morning talks cover external translational perspective and Wyss Zurich's experience with GxP and regulatory challenges in clinical translation.
12:00-13:15
Lunch
A mid-day break for informal discussion with speakers, peers, and the ACROBiosystems team.
13:15-14:15
Manufacturing and next-generation therapy development
Afternoon sessions examine GMP manufacturing lessons and the shift from ex vivo to in vivo strategies in cell and gene therapy.
14:30-15:30
Clinical translation and control strategy
The final technical block covers retinal cell therapy translation and microbiological control strategies for cell-based preparations.
15:30-17:00
Closing remarks and apéro
The day closes with final remarks, a raffle announcement, and time to continue conversation during the apéro.
Why Learn with ACRO?
Learn from active translational programmes
Hear how leaders from Karolinska Institutet, Wyss Zurich, Somagenetix, King’s College London, Labor LS, and ACROBiosystems approach the scientific, manufacturing, and regulatory work that shapes clinical translation.
Navigate GxP and regulatory challenges
Explore key GxP and regulatory considerations when transitioning from research into clinical manufacturing. Sessions cover qualified materials, validation, documentation, cleanroom operations, microbiological control, scale-up, and the balance between innovation and manufacturability in cell therapy development.
Connect with peers and collaborators
Spend the day with innovators across cell therapy and biopharma R&D, then continue conversations with speakers and attendees during lunch and the networking apéro.
For any questions for the workshop, please send emails to mkteu@acrobiosystems.com.
ACROBiosystems
ACROBiosystems provides innovative life science solutions that support customers from discovery through clinical translation in the biopharma industry.
Questions about the workshop? Contact the ACROBiosystems events team.